Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia

Journal of Internal Medicine

Volumn 258, Issue 4, 2005, Pages 349-355

  Kjeldsen, Anette Drøhse ^a   Moller T R ^a   Brusgaard, K ^a   Vase, P ^b   Andersen, P E ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b SVENDBORG HOSPITAL   (Denmark)

Author keywords

Epistaxis; Hereditary haemorrhagic telangiectasia; Mb.Osler; Pulmonary arteriovenous malformation

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN ARTERIOVENOUS MALFORMATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SURVIVAL;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ARTERIOVENOUS MALFORMATIONS; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PREVALENCE; PULMONARY ARTERY; PULMONARY VEINS; RECEPTORS, CELL SURFACE; SURVIVAL RATE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 25444530657     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01555.x     Document Type: Article

References (24)

1. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54: 714-729.
2. Vase P. Telangiectasia haemorrhagica hereditaria, Mb.Osler (En epidemiologisk, genetisk og klinisk undersøgelse). Odense: Odense University, 1988; 1-159.
3. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995; 99: 519-24.
4. Kjeldsen AD, Oxhøj H, Andersen PE, Green A, Vase P. Prevalence of pulmonary arteriovenous malformations (PAVM) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT). Intern Med 2000; 248: 255-62.
5. White RI Jr, Lynch Nyhan A, Terry P et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988; 169: 663-9.
6. Andersen PE, Kjeldsen AD, Oxhoj H, Vase P, White R. Embolotherapy for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Acta Radiol 1998; 39: 723-6.
7. Maher CO, Piepgras DG, Brown RD, Friedman JA, Pollock BE. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32: 877-82.
8. Willemse RB, Mager JJ, Westermann CJJ, Overtoom TTC, Mauser H, Wolbers JG. Bleeding risk of Cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2000; 92: 779-84.
9. Easey AJ, Wallace GMF, Hughes JM, Jackson JE, Taylor WJ, Shovlin CL. Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22061 years of HHT patient life. J Neurol Neurosurg Psychiatry 2003; 74: 743-8.
10. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?. J Med Genet 1996; 33: 256-7.
11. Berg J, Porteous M, Reinhardt D et al. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 2003; 40: 585-90.
12. Gallione CJ, Repetto GM, Legius E et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). The Lancet 2004; 363: 852-9.
13. Kjeldsen AD. Epidemiological and clinical aspects of hereditary haemorrhagic telangiectasia. Mb. Osler. Thesis. Odense. Denmark: Odense University. 1998; 1-79.
14. Kjeldsen AD, Vase P, Green A. Hereditary hemorrhagic telangiectasia, HHT. A population-based study of prevalence and mortality in Danish HHT patients. J Intern Med 1999; 245: 31-41.
15. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-7.
16. Kjeldsen AD, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2000; 95: 415-8.
17. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the task Force on stroke and other Cerebrovascular disorders. Stroke 1989; 20: 1407-31.
18. Kjeldsen AD, Oxhøj H, Andersen PE, Elle B, Jacobsen JP. Vase P. Pulmonary arteriovenous malformations, screening procedures and pulmonary angiography in HHT patients. Chest 1999; 116: 432-40.
19. Brusgaard K, Kjeldsen AD, Poulsen L et al. Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet 2004; 66: 556-61.
20. Fischer SG, Lerman LS. Separation of random fragments of DNA according to properties of their sequences. Proc Natl Acad Sci USA 1980; 77: 4420-4.
21. Sisel RJ, Parker BM, Bahl OP. Cerebral symptoms in pulmonary arteriovenous fistula. A result of paradoxical emboli(?). Circulation 1970; 41: 123-8.
22. McAllister KA, Lennon F, Bowles Biesecker B et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 1994; 31: 927-32.
23. Abdalla S, Geisthoff U, Bonneau D et al. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003; 40: 494-502.
24. Shovlin CL, Winstock AR, Peters AM, Jackson JE. Hughes JMB. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. Q J Med 1995; 88: 879-87.